Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone Deacetylase 10 (HDAC10) is a class IIb histone deacetylase enzyme involved in regulating chromatin structure, gene expression, and cellular processes like autophagy and DNA repair. It exhibits robust polyamine deacetylase activity, particularly towards N8-acetylspermidine. HDAC10 is implicated in cancer due to its roles in cell survival and proliferation pathways, making it a potential therapeutic target for selective inhibitor development.
Inhibition of histone and polyamine deacetylation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone Deacetylase 10 (HDAC10).